AbbVie to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

AbbVie will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021. The event will feature presentations from key executives including Richard A. Gonzalez, Michael Severino, Robert A. Michael, and Jeffrey R. Stewart. The presentation is scheduled for 3:30 p.m. Central time and will be accessible via a live audio webcast on AbbVie's Investor Relations website. An archived version will be available later that same day.

AbbVie focuses on innovative medicines across multiple therapeutic areas, including immunology, oncology, and neuroscience.

NORTH CHICAGO, Ill., Jan. 6, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 39^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Members of AbbVie's executive leadership team will present virtually at 3:30 p.m. Central time, including Richard A. Gonzalez, chairman of the board and chief executive officer, Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301201327.html

SOURCE AbbVie

FAQ

When will AbbVie present at the 39th Annual J.P. Morgan Healthcare Conference?

AbbVie will present on January 12, 2021, at 3:30 p.m. Central time.

Who are the key speakers from AbbVie at the conference?

The speakers include Richard A. Gonzalez, Michael Severino, Robert A. Michael, and Jeffrey R. Stewart.

Where can I listen to the AbbVie presentation at the conference?

The presentation will be available via a live audio webcast on AbbVie's Investor Relations website.

Will there be a recording of AbbVie's conference presentation?

Yes, an archived edition of the presentation will be available later on January 12, 2021.

What focus areas does AbbVie concentrate on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.